Business Context and Reporting Period
Invivyd, Inc. filed a Form 8-K reporting matters from its May 21, 2024 Annual Meeting of Stockholders. The filing was signed and furnished on May 22, 2024. Invivyd’s common stock trades on Nasdaq under the symbol IVVD.
Financial Metrics and Capital Position
This filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial performance metrics.
Material Changes and Meeting Results
- Stockholders elected Tamsin Berry, Sara Cotter, Marc Elia, Srishti Gupta, M.D., Christine Lindenboom, Terrance McGuire, and Kevin McLaughlin as directors for one-year terms expiring at the 2025 annual meeting.
- Each director nominee received a majority of votes cast in favor. Votes for ranged from 83.0 million to 92.5 million; broker non-votes totaled 4.6 million for each nominee.
- Stockholders ratified PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, with 98.7 million votes for, 90,855 against, and 67,029 abstentions.
Guidance, Outlook, Risks, and Unusual Items
- The filing provides no financial guidance, operating outlook, management discussion, contingencies, or risk updates.
- The company furnished a May 22, 2024 press release titled “Invivyd Elects Two New Independent Members to its Board of Directors.” The text supplied does not include the press release content or clearly identify the two new members.
- The filing contains corporate governance and auditor-ratification information rather than operating or financial results.
Key Facts for Investors to Verify
- Review the furnished Exhibit 99.1 press release to identify the two new independent directors and understand any related board changes.
- Confirm the elected directors’ roles, committee assignments, and independence status in subsequent filings.
- Refer to Invivyd’s periodic financial reports for current cash, liquidity, financing needs, operating results, and forward-looking guidance, none of which is provided here.